GoodRx (GDRX) announced a new direct contracting agreement with The Kroger Co. (KR) to deliver improved prescription pricing at more than 2,200 Kroger family pharmacy locations nationwide. A key focus for GoodRx in recent years has been transforming how it delivers value to retail pharmacies. By leveraging its direct-contracting model, GoodRx and Kroger have reached a mutually beneficial agreement that enables them to deliver lower prices directly to patients. Starting June 1, 2024, patients can present a GoodRx coupon at Kroger Family of Pharmacies to receive almost 50% more savings on the expected patient price for most generics, compared to previously available prices on their prescription medications.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GDRX:
- GoodRx sees 2024 revenue $800M-$810M, consensus $800.99M
- GoodRx sees Q2 revenue approx. $200M, consensus $199.68M
- GoodRx reports Q1 adjusted EPS 8c, consensus 7c
- Notable companies reporting before tomorrow’s open
- Investors in GoodRx Holdings, Inc. Should Contact Levi & Korsinsky LLP Before June 21, 2024 to Discuss Your Rights – GDRX
